Author Correction:α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice  

作　　者：Xin Chen Jie Liu Jie Liu Wen-jia Wang Wen-jing Lai Shu-hui Li Ya-fei Deng Jian-zhi Zhou Sheng-qian Yang Ying Liu Wei-nian Shou Da-yan Cao Xiao-hui Li 

机构地区：[1]Institute of Materia Medica and Center of Translational Medicine,College of Pharmacy,Army Medical University,Chongqing 400038,China [2]Department of Pharmacy,Xinqiao Hospital,Army Medical University,Chongqing 400037,China [3]Department of Clinical Biochemistry,College of Pharmacy,Army Medical University,Chongqing 400038,China [4]Hunan Children’s Research Institute(HCRI),Hunan Children’s Hospital,Changsha 410007,China [5]School of Medicine,Chongqing University,Chongqing 400016,China [6]Department of Pediatrics,Herman B Wells Center for Pediatric Research,Indiana University School of Medicine,Indianapolis,IN,USA

出　　处：《Acta Pharmacologica Sinica》2022年第7期1875-1878,共4页中国药理学报（英文版）

摘　　要：During our recent check of our published article entitled“α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice”published in Acta Pharmacologica Sinica.We realized that there were several mistakes in the final assemble of figures:(1)in Figs.2a and 4a,representative images of Masson staining were obtained at 20×rather than 2×;(2)in Figs.2g and 4g,representative images of echocardiography were mis-placed in the process of assembling figures;(3)in Fig.8d,the chemokine determined is MIP-1αrather than MCP-1α.However,these mistakes do not affect the conclusions of the original article nor the text of the article and the figure legends.We apologize sincerely for any inconvenience caused.

关 键 词：PATHOGENESIS cardiac injury 

分 类 号：R96[医药卫生—药理学]